Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Petra Kowalski"'
Publikováno v:
Californian Journal of Health Promotion. 11:84-96
A non-equivalent control group design was utilized to investigate the effect of a non-diet, peer-led, tailored nutrition and exercise adherence intervention (FitU) on exercise stages of change, intuitive eating, and barriers to healthy eating and exe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a383f6bb369274712fec22d10cfbe44
https://doi.org/10.32398/cjhp.v11i1.1521
https://doi.org/10.32398/cjhp.v11i1.1521
Publikováno v:
Molecular Therapy. 11(4):508-522
A "multitarget multiribozyme" (MTMR) was constructed. It consists of three trans-acting hammerhead ribozymes directed against the transcripts of the ABC transporters MDR1/P-gp, BCRP, and MRP2; three cis-acting MDR1/P-gp-specific ribozymes; and three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5c7ae886b699aba69bce139d2dbd769
Autor:
Alexandra Stege, Holger Tönnies, Franziska Rompe, Axel Priebsch, Pawel Surowiak, Verena Materna, Hermann Lage, Petra Kowalski
Publikováno v:
Oligonucleotides. 16(3)
In the chemotherapeutic treatment of patients with disseminated neoplasms, multidrug resistance (MDR) is a major obstacle. ABCG2 (BCRP/MXR), a member of the superfamily of adenosine triphosphate-binding cassette (ABC) transporters, was demonstrated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::711a18f9fbcd9a1f1fbfa84db986b5f5
https://pubmed.ncbi.nlm.nih.gov/16978089
https://pubmed.ncbi.nlm.nih.gov/16978089
Publikováno v:
Anticancer research. 24(4)
Ribozymes are an effective tool to reduce the mRNA levels of specific target genes. Overexpression of the drug transport protein, ABCG2, has been associated with multidrug resistance in cancer cells.An expression plasmid encoding a hammerhead ribozym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2b1606036768835f7f8691828ce0a8f4
https://pubmed.ncbi.nlm.nih.gov/15330166
https://pubmed.ncbi.nlm.nih.gov/15330166
Publikováno v:
Cancer gene therapy. 9(7)
The phenomenon of multidrug resistance (MDR) in human cancers is one of the major causes of failure of chemotherapy. A recently identified new member of the superfamily of ATP-binding cassette transporters, breast cancer resistance protein (BCRP), wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c4d60d2a4972092aa5f86424854ef59
https://pubmed.ncbi.nlm.nih.gov/12082458
https://pubmed.ncbi.nlm.nih.gov/12082458
Publikováno v:
Cancer gene therapy. 8(3)
Breast cancer resistance protein (BCRP) is a recently identified new member of the superfamily of ATP-binding cassette transporters. BCRP is a “half transporter” that may homo- or heterodimerize to form an active transport complex. A considerable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3389a9a1c0864d039521c4a662b0666d
https://pubmed.ncbi.nlm.nih.gov/11332989
https://pubmed.ncbi.nlm.nih.gov/11332989
Autor:
Axel Priebsch, Franziska Rompe, Holger Tönnies, Petra Kowalski, Pawel Surowiak, Alexandra Stege, Verena Materna, Hermann Lage
Publikováno v:
Oligonucleotides; Fall2006, Vol. 16 Issue 3, p263-274, 12p